09:45 AM EST - Advanced Proteome Therapeutics Corporation : Announced a collaboration with the National Research Council of Canada. Through this arrangement both parties have forged a strategic relationship to further the development of antibody-drug conjugates. Advanced Proteome Therapeutics Corporation
shares V.APC are trading unchanged at $0.06.
